The weekly litigation news digest is live. Subscribe now

IP Verse

Santen Pharmaceutical competitive analysis

Loading summary...

Latest patents of Santen Pharmaceutical opposed by its competitors

Explore Santen Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3463360
Aug 31, 2022Atropine-Containing Aqueous Composition2
EP3714877
Jan 26, 2022Method And Composition For Treating Ocular Hypertension And Glaucoma3
EP3205334
Apr 29, 2020Method And Composition For Treating Ocular Hypertension And Glaucoma1
EP2772249
May 3, 2017Method And Composition For Treating Ocular Hypertension And Glaucoma1

Latest PTAB cases involving Santen Pharmaceutical

Discover the latest PTAB cases involving Santen Pharmaceutical, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 20, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Santen Pharmaceutical

IPR2017-01434May 12, 2017MICRO LABSSANTEN PHARMACEUTICALFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Santen Pharmaceutical with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 20, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SANTEN PHARMACEUTICAL - 7 - 1
BECKER61 - -
COOKE27 - - -
DE GREGORI1 - - -